Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 15, Issue 8, 2009, Pages 1233-1239

  Nguyen, Geoffrey C ^a,b,d   LaVeist, Thomas A ^c   Harris, Mary L ^b   Datta, Lisa W ^b   Bayles, Theodore M ^b   Brant, Steven R ^a,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE   (Canada)

Author keywords

Adherence; African American; Black; Crohn's disease; Inflammatory bowel disease; Race; Trust in physician; Ulcerativecolitis

Indexed keywords

INFLIXIMAB;

ARTICLE; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; ENTERITIS; ETHNICITY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; NEGRO; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RACE DIFFERENCE; SENSITIVITY ANALYSIS; SOCIAL STATUS; TRUST;

ADULT; AFRICAN AMERICANS; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH BEHAVIOR; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; TREATMENT OUTCOME; TRUST;

EID: 70349479006     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20883     Document Type: Article

References (34)

1. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003; 114:39-43.
2. Bernal I, Domenech E, Garcia-Planella E, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci. 2006;51:2165-2169.
3. Cerveny P, Bortlik M, Kubena A, et al. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis. 2007;13: 1244-1249.
4. Kane SV, Cohen RD, Aikens JE, et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929-2933.
5. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426.
6. Thom DH, Ribisl KM, Stewart AL, et al. Further validation and reliability testing of the Trust in Physician Scale. The Stanford Trust Study Physicians. Med Care. 1999;37:510-517.
7. Schneider J, Kaplan SH, Greenfield S, et al. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004; 19:1096-1103.
8. Piette JD, Heisler M, Krein S, et al. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165:1749-1755.
9. O'Malley AS, Sheppard VB, Schwartz M, et al. The role of trust in use of preventive services among low-income African-American women. Prev Med. 2004;38:777-785.
10. Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007;22:1572-1578.
11. Casagrande SS, Gary TL, LaVeist TA, et al. Perceived discrimination and adherence to medical care in a racially integrated community. J Gen Intern Med. 2007;22:389-395.
12. Boulware LE, Cooper LA, Ratner LE, et al. Race and trust in the health care system. Public Health Rep. 2003;118:358-365.
13. Rawaf MM, Kressin NR. Exploring racial and sociodemographic trends in physician behavior, physician trust and their association with blood pressure control. J Natl Med Assoc. 2007;99:1248-1254.
14. Armstrong K, Ravenell KL, McMurphy S, et al. Racial/ethnic differences in physician distrust in the United States. Am J Public Health. 2007;97:1283-1289.
15. Stepanikova I, Mollborn S, Cook KS, et al. Patients' race, ethnicity, language, and trust in a physician. J Health Soc Behav. 2006;47:390-405.
16. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994;106:287-296.
17. Sandler RS, Jordan MC, Kupper LL. Development of a Crohn's index for survey research. J Clin Epidemiol. 1988;41:451-458.
18. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29-32.
19. Anderson LA, Dedrick RF. Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 1990;67:1091-1100.
20. Kim MT, Hill MN, Bone LR, et al. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15:90-96.
21. Lemann M, Mary JY, Colombel JF, et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology. 2005;128:1812-1818.
22. Rawaf MM, Kressin NR. Exploring racial and sociodemographic trends in physician behavior, physician trust and their association with blood pressure control. J Natl Med Assoc. 2007;99:1248-1254.
23. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282:583-589.
24. Fiscella K, Meldrum S, Franks P, et al. Patient trust: is it related to patient-centered behavior of primary care physicians? Med Care. 2004; 42:1049-1055.
25. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003; 98:1535-1544.
26. Morris AB, Li J, Kroenke K, et al. Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy. 2006;26:483-492.
27. Jackson JF, Kornbluth A. Do black and Hispanic Americans with inflammatory bowel disease (IBD) receive inferior care compared with white Americans? Uneasy questions and speculations. Am J Gastroenterol. 2007;102:1343-1349.
28. Cooper LA, Roter DL, Johnson RL, et al. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med. 2003;139:907-915.
29. Rozenfeld Y, Hunt JS, Plauschinat C, et al. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14:71-75.
30. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27:1064-1073.
31. Bosworth HB. Medication treatment adherence. In: Bosworth HB, Oddone EZ, Weinberger M, eds. Patient Treatment Adherence, Concepts, Interventions, and Measurement. Mahwah, NJ: Lawrence Erlbaum Associates; 2006:147-194.
32. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757-764.
33. Fleece L, Summers MA, Schnaper H, et al. Adherence to pharmacotherapeutic regimen. Assessment and intervention. Ala J Med Sci. 1988;25: 389-393.
34. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24:67-74.